Transaction in Own Shares

RNS Number : 0283V
NatWest Group plc
31 March 2023
 

NatWest Group plc

31 March 2023


Transaction in Own Shares

NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS').









Aggregated information:

 












Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume  weighted average price paid per share (GBp)

Venue


31 March 2023

2,560,992

264.70

262.30

263.7816

LSE


31 March 2023

866,663

264.80

262.30

263.7845

CHIX


31 March 2023

1,600,970

264.70

262.30

263.8152

BATE









* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share


Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023.









The Company intends to cancel the repurchased Ordinary Shares.








Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,586,145,646 Ordinary Shares in issue (excluding treasury shares).









Further information:








Investor Relations







+ 44 (0)207 672 1758













Media Relations







+44 (0)131 523 4205













Legal Entity Identifier: 2138005O9XJIJN4JPN90








Transaction details

 





In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK
(Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf
of the Company as part of the buyback programme is available here: http://www.rns-pdf.londonstockexchange.com/rns/0283V_1-2023-3-31.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKDBPABKDANN
UK 100

Latest directors dealings